Fibulin-5 as a potential therapeutic target in COPD

Corry-Anke Brandsma; Maarten van den Berge; Dirkje Postma; Wim Timens

doi:10.1517/14728222.2016.1164696

Fibulin-5 as a potential therapeutic target in COPD

Corry-Anke Brandsma, Maarten van den Berge, Dirkje Postma, Wim Timens^*

^*Corresponding author voor dit werk

Groningen Research Institute for Asthma and COPD

Onderzoeksoutput: Editorial › Academic › peer review

5 Citaten (Scopus)

Originele taal-2	English
Pagina's (van-tot)	1031-1033
Aantal pagina's	3
Tijdschrift	EXPERT OPINION ON THERAPEUTIC TARGETS
Volume	20
Nummer van het tijdschrift	9
DOI's	https://doi.org/10.1517/14728222.2016.1164696
Status	Published - 2016

Toegang tot document

10.1517/14728222.2016.1164696

Handle.net

Permanente koppeling

Document onder embargo

Fibulin-5 as a potential therapeutic target in COPD
Final publisher's version, 674 KB
Kopie aanvragen

Citeer dit

@article{3085f71eeb22457391ecb640c10ba3ec,

title = "Fibulin-5 as a potential therapeutic target in COPD",

keywords = "COPD, emphysema, elastic fiber, fibrosis, fibulin-5, TGF-BETA, IN-VIVO, GENE-EXPRESSION, ELASTIN, REPAIR, FIBROBLASTS, FIBROSIS",

author = "Corry-Anke Brandsma and {van den Berge}, Maarten and Dirkje Postma and Wim Timens",

year = "2016",

doi = "10.1517/14728222.2016.1164696",

language = "English",

volume = "20",

pages = "1031--1033",

journal = "EXPERT OPINION ON THERAPEUTIC TARGETS",

issn = "1472-8222",

publisher = "Taylor & Francis Group",

number = "9",

}

TY - JOUR

T1 - Fibulin-5 as a potential therapeutic target in COPD

AU - Brandsma, Corry-Anke

AU - van den Berge, Maarten

AU - Postma, Dirkje

AU - Timens, Wim

PY - 2016

Y1 - 2016

KW - COPD

KW - emphysema

KW - elastic fiber

KW - fibrosis

KW - fibulin-5

KW - TGF-BETA

KW - IN-VIVO

KW - GENE-EXPRESSION

KW - ELASTIN

KW - REPAIR

KW - FIBROBLASTS

KW - FIBROSIS

U2 - 10.1517/14728222.2016.1164696

DO - 10.1517/14728222.2016.1164696

M3 - Editorial

C2 - 26962995

SN - 1472-8222

VL - 20

SP - 1031

EP - 1033

JO - EXPERT OPINION ON THERAPEUTIC TARGETS

JF - EXPERT OPINION ON THERAPEUTIC TARGETS

IS - 9

ER -